PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women\'s Hospital, Harvard Medical School, Boston, MA, United States.\', \'Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.\', \'Santa Casa de Misericordia de Santos, Santos, Brazil.\', \'Tiziana LifeScience, Doylestown, PA, United States.\', \'Department of Radiology, Boston Children\'s Hospital, Harvard Medical School, Boston, MA, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.709861
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34475873
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34475873>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34475873>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all